These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemical studies on tuberactinomycin. XVI. Synthesis of tuberactinomycin N. Shiba T, Ando T, Teshima T. J Antibiot (Tokyo); 1979 Oct; 32(10):1078-9. PubMed ID: 528372 [No Abstract] [Full Text] [Related]
4. Chemical studies on tuberactinomycin. VIII. Isolation of tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, and conversion of tuberactinomycin N to O. Wakamiya T, Shiba T. J Antibiot (Tokyo); 1975 Apr; 28(4):292-7. PubMed ID: 808523 [Abstract] [Full Text] [Related]
5. Chemical studies on tuberactinomycin. XV. Total synthesis of tuberactinomycin O. Teshima T, Nomoto S, Wakamiya T, Shiba T. J Antibiot (Tokyo); 1977 Dec; 30(12):1073-9. PubMed ID: 599082 [Abstract] [Full Text] [Related]
7. Binding of [14C]tuberactinomycin O, an antibiotic closely related to viomycin, to the bacterial ribosome. Misumi M, Tanaka N, Shiba T. Biochem Biophys Res Commun; 1978 Jun 14; 82(3):971-6. PubMed ID: 212033 [No Abstract] [Full Text] [Related]
10. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic. Toyoara M. Bull Int Union Tuberc; 1974 Aug 14; 49 suppl 1():288-91. PubMed ID: 4468026 [No Abstract] [Full Text] [Related]
14. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)]. Tsukamura M, Mizuno S, Murata H, Oshima T. Kekkaku; 1975 May 14; 50(4-5):123-30. PubMed ID: 49449 [No Abstract] [Full Text] [Related]
15. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. Tsukamura M, Mizuno S. J Gen Microbiol; 1975 Jun 14; 88(2):269-74. PubMed ID: 50402 [Abstract] [Full Text] [Related]
16. Binding of [14C]tuberactinomycin O to ribosomes from Mycobacterium smegmatis. Yamada T, Teshima T, Shiba T. J Antibiot (Tokyo); 1985 Feb 14; 38(2):266-9. PubMed ID: 2987173 [No Abstract] [Full Text] [Related]
17. [Tuberactinomycin-N (enviomycin-EVM) in the treatment of pulmonary tuberculosis (author's transl)]. Ishikawa H, Nakashima N, Okada H, Tsutsumi T, Ishizaki T, Oka R, Oda T, Shigeno Y, Yamaguchi K, Nakatomi M, Hara K. Kekkaku; 1981 Jul 14; 56(7):369-74. PubMed ID: 6276611 [No Abstract] [Full Text] [Related]
18. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)]. Tsukamura M. Kekkaku; 1978 Oct 14; 53(10):495-8. PubMed ID: 102861 [No Abstract] [Full Text] [Related]
20. [A study on therapeutic effect of enviomycin (tuberactin) in retreatment for pulmonary tuberculosis (author's transl)]. Yamamoto K, Aizawa H, Inoue I, Nagai S, Yamazaki M, Konishiike J, Kitatani F, Asahi T, Bessho M, Mitsufuji Y, Nakata S, Sugihara F, Tatsumi N, Kobayashi M, Matsutani Y, Yuba M, Okamoto S, Tsujimoto T, Yamaguchi S, Iwai K, Iwata S, Fukui S, Sawai A, Watanabe Y, Kakuno J, Nishizawa N. Kekkaku; 1978 Feb 14; 53(2):107-113. PubMed ID: 633702 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]